Enter your login e-mail to the account
Search
Search parameters
Search results
- Endokrinné a metabolické účinky fyzického tréningu pacientov s hypogonadizmom
Mgr. Milan Sedliak, PhD., LitT., Doc. MUDr. Barbara Ukropcová, PhD., prof. MUDr. Juraj Payer, PhD., MPH, FRCP
(4/2018, Review articles ) - New trends in metastatic hormone-sensitive prostate cancer treatment
prof. MUDr. Ján Kliment, CSc.
(2/2020, Interdisciplinary consilium ) - Tlačové správy
(4/2010, Information & comments )
- ACTUAL MEDICATION OF THE BONE METASTASE
MUDr. Ivan Kolombo, FEBU, MUDr. Martina Poršová, MUDr. Jaroslav Porš, MUDr. Richard Pabišta
(5-6/2007, Review articles ) - Androgen deprivation therapy of prostate cancer and cardiovascular morbidity
MUDr. Otakar Čapoun, Ph.D., FEBU
(4/2019, Review articles ) - New treatment options in hormone-sensitive prostate cancer
MUDr. Otakar Čapoun, Ph.D., FEBU
(5/2019, Review articles ) - Consequences of genitourinary malignancies therapy on cardiovascular system
Prof. MUDr. Beata Mladosievičová, CSc., MUDr. Lucia Petríková, RNDr. Zuzana Poljak Valášková, Ph.D.
(5/2018, Review articles ) - Therapy of prostate cancer in elderly patients
MUDr. Otakar Čapoun, Ph.D., FEBU
(3/2022, Review articles ) - THE COST OF HORMONAL THERAPY FOR PROSTATE CANCER – PHARMACOECONOMIC ASPECTS OF TREATMENT INDICATIONS
doc. MUDr. Miroslav Hanuš, CSc., MUDr. Michaela Matoušková
(1/2008, Review articles ) - CHEMOTHERAPY OF HORMONALLY REFRACTORY PROSTATIC CARCINOMA
doc. MUDr. Jozef Mardiak, CSc.
(2/2007, Review articles ) - Have we found an optimal sequence in the treatment of metastatic castrationally-resistant prostate cancer?
MUDr. Tomaš Svoboda, Ph.D.
(1/2019, Review articles ) - NEW RECOMMENDATIONS FOR HORMONAL THERAPY OF PROSTATE CANCER IN COMBINATION WITH RADIOTHERAPY
MUDr. Viktor Vik, doc. MUDr. Roman Zachoval, Ph.D., MUDr. Vladislav Klemenc, MUDr. Miroslav Záleský
(5-6/2007, Review articles )
- Overview of treatment of castration-resistant prostate cancer
MUDr. Jana Obertová
(4/2012, Review articles ) - Castration resistant prostate cancer in the year 2013
doc. MUDr. Jozef Marenčák, PhD.
(3/2013, Review articles ) - Chemotherapy of hormonally refractory prostatic carcinoma
doc. MUDr. Jozef Mardiak, CSc.
(1/2007, Review articles ) - Current recommendations for bisphosphonates therapy in cancer patients
prof. MUDr. Stanislav Špánik, CSc., MUDr. Beata Špániková, PhD.
(6/2013, Review articles ) - Non-metastatic castration-resistant prostate cancer
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M., MUDr. Ján Slopovský
(3/2019, Review articles ) - Immunotherapy and targeted treatment for metastatic, castration-resistant prostate cancer
MUDr. Ján Slopovský, JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2022, Main topic ) - What are the current trends in external beam radiotherapy for localized prostate cancer?
doc. MUDr. Pavol Dubinský, PhD., MHA
(4/2023, Main topic ) - Current treatment options for metastatic hormone-sensitive prostate cancer
MUDr. Jana Obertová, PhD.
(4/2023, Main topic ) - Review on castrate-resistant prostate carcinoma systemic therapy
Doc. JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2023, Main topic ) - Optimization of radiotherapy of high-risk prostate cancer
doc. MUDr. Pavol Dubinský, PhD., MHA
(5/2019, Main topic ) - A comprehensive view of the treatment of metastatic hormone sensitive prostate cancer
prof. MUDr. Ján Kliment, CSc., MUDr. Ing. Monika Kuzma, MBA
(5/2019, Main topic ) - Current possibilities and view of treatment of castration refractory metastatic prostate cancer
MUDr. Radovan Barilla, PhD.
(5/2019, Main topic ) - Metastatic prostate cancer: principles of hormonal treatment
Doc. MUDr. Frederico Goncalves, PhD.
(4/2014, Main topic ) - Castration resistant prostate cancer – something new in the year 2014?
doc. MUDr. Jozef Marenčák, PhD.
(4/2014, Main topic ) - RADIOTHERAPY PROSTATE CANCER
MUDr. Pavol Dubinský, PhD.
(5/2008, Review articles ) - Správy z podujatia ASCO Chicago 2014
prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková, MUDr. Patrik Palacka, PhD. MPH, MBA
(4/2014, Events ) - Treatment of patient with metastatic castrate refractory prostate cancer after androgen deprivation therapy failure
MUDr. Jozef Babeľa, PhD.
(S1/2019, Case reports ) - Favourable therapeutic response of enzalutamide in patient with metastatic castration resistant prostate cancer
MUDr. Martin Romančík, PhD., MPH
(S1/2019, Case reports ) - Enzalutamide in treatment of the metastatic castration resistant prostate cancer
Doc. MUDr. Jozef Marenčák, PhD.
(6/2017, Drugs & drug classes ) - New possibilities and view for treatment of castration resistent prostate cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2012, Review articles ) - Metastatic prostate cancer - new therapeutical approaches
MUDr. Patrik Palacka, PhD., MPH, MBA, Mgr. Soňa Herudová
(2/2015, Review articles ) - Changes of bone mineral density in patients with testicular cancer
doc. MUDr. Jozef Mardiak, CSc., prof. MUDr. Juraj Payer, CSc., MUDr. Beata Špániková
(6/2012, Main topic ) - Early prostate cancer: particularities of treatment
Doc. MUDr. Frederico Goncalves, PhD.
(1/2017, Review articles ) - Chemotherapy of hormone refractory prostate cancer
MUDr. Marta Škultétyová, MUDr. Andrea Mocná
(5/2009, Review articles ) - First-line treatment of metastatic castration-sensitive prostate cancer
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M., MUDr. Ján Slopovský
(3/2022, Review articles ) - Adjuvant therapy of prostate cancer
MUDr. Pavol Dubinský, PhD.
(5/2009, Review articles ) - Abiraterone in treatment of metastatic castrate resistant prostate cancer
prof. MUDr. Ján Kliment, CSc.
(2/2014, Drugs & drug classes ) - Glukokortikoidy v liečbe kastračne-rezistentného karcinómu prostaty a mechanizmy rezistencie na androgénnu blokádu
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2018, Review articles ) - Androgen deprivation therapy and radiotherapy of prostate cancer
doc. MUDr. Pavol Dubinský, PhD.
(5/2018, Review articles )